Issue of shares
Promisia Ltd
22 Panama St,
Wellington,
New Zealand 6011
DDI +64 4 499 5563
Mobile +64 21 571 000
E rene@promisia.com
PROMISIA.COM
5 November 2019
Issue of Shares following payment in full on exercise of an option to subscribe for shares
(Updated Allotment Notice)
The directors of Promisia Integrative Limited advise that a total of 250,000,000 new shares have
been issued by the company today to the Brankin Trust following the completion of payments to
exercise an option to subscribe for shares.
This transaction was approved by shareholders on 4 December 2018 and the decision by Brankin
Trust to exercise its option was advised to the market on 22 January 2019. Brankin Trust has made
progressive payments to the company over the last 10 months and the sum of $250,000 is now paid
in full and the shares can be issued as fully paid.
The directors thank the Brankin Trust for its support and the provision of funding as the company
awaits resolution of its prosecution by the Ministry of Health.
Please find the Allotment Notice pursuant to Listing Rule 3.13.1 attached.
Stephen Underwood 027 499 3387
---
Template
Capital Change Notice
Updated as at 8 May 2019
Section 1: Issuer information
Name of issuer Promisia Integrative Limited
NZX ticker code PIL
Class of financial product Ordinary Shares
ISIN (If unknown, check on NZX website) NZPRPE0001S5
Currency NZD
Section 2: Capital change details
Number issued/acquired/redeemed 250,000,000 shares issued
Nominal value (if any) Nil
Issue/acquisition/redemption price per security $0.001
Nature of the payment (for example, cash or other
consideration)
Cash
Amount paid up (if not in full) Fully paid
Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the number of
Financial Products of the Class, excluding any Treasury Stock,
in existence)
1
11.62%
For an issue of Convertible Financial Products or Options, the
principal terms of Conversion (for example the Conversion
price and Conversion date and the ranking of the Financial
Product in relation to other Classes of Financial Product) or the
Option (for example, the exercise price and exercise date)
N/A
Reason for issue/acquisition/redemption and specific authority
for issue/acquisition/redemption/ (the reason for change must
be identified here)
Raise working capital.
Resolution of shareholders at
a special meeting of
shareholders held 4 December
2018
Total number of Financial Products of the Class after the
issue/acquisition/redemption/Conversion (excluding Treasury
Stock) and the total number of Financial Products of the Class
held as Treasury Stock after the issue/acquisition/redemption.
2,151,797,451
In the case of an acquisition of shares, whether those shares
are to be held as treasury stock
N/A
Specific authority for the issue, acquisition, or redemption,
including a reference to the rule pursuant to which the issue,
acquisition, or redemption is made
Shareholders approved the
issue of the shares in
compliance with the
requirements of Rules 79 7(c)
and 7(d) of the Takeovers
Code and NZX Listing Rules
7.5.1 (as applicable) and 9.2.1.
1
The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.
Terms or details of the issue, acquisition, or redemption (for
example: restrictions, escrow arrangements)
The shares were issued
pursuant to an option to
acquire up to 250,000,000
shares at an issue price of
$0.001 per share. The option
was a term of an underwriting
agreement with respect to a
Rights Issue approved by
shareholders on 4 December
2018. The shares could not be
issued until they became fully
paid.
Date of issue/acquisition/redemption
2
04/11/2019
Section 3: Authority for this announcement and contact person
Name of person authorised to make this announcement Stephen Underwood
Contact person for this announcement Stephen Underwood
Contact phone number 027 499 3387
Contact email address stephen@renouf.co.nz
Date of release through MAP 05/11/2019
2
Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant
issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- FPH — Fisher & Paykel Healthcare Corporation Limited: Notification of Issue of Securities2019-09-30
“Page 1 of 2 30 September 2019 Issue of ordinary shares This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of ordinary shares in Fisher & Paykel Healthcare Corporation Limited (“FPH”) under the Fisher & Paykel Healthcare 2003 Share Option Plan. This…”
- FPH — Fisher & Paykel Healthcare Corporation Limited: Notification of Issue of Securities2019-12-05
“Page 1 of 2 6 December 2019 Issue of ordinary shares This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of ordinary shares in Fisher & Paykel Healthcare Corporation Limited (“FPH”) under the Fisher & Paykel Healthcare 2003 Share Option Plan. This no…”
- FPH — Fisher & Paykel Healthcare Corporation Limited: Notification of Issue of Securities2019-12-20
“Page 1 of 2 20 December 2019 Issue of ordinary shares This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of ordinary shares in Fisher & Paykel Healthcare Corporation Limited (“FPH”) under the Fisher & Paykel Healthcare 2003 Share Option Plan. This no…”